Clinical Trial Update: Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating stimulation of the cholinergic anti-inflammatory pathway to prevent and treat systemic inflammatory response syndrome in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Jaundice
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Wanqing Gu | Conditions: Systemic Inflammatory Response Syndrome, Jaundice, Obstructive | Phase 1, Phase 2 | Status: UNKNOWN